Retinal Changes: In Patients of Chronic Hepatitis C Treated with Interferon Alpha- Ribavirin Combination Therapy

Authors

  • SALMAN JAVED MUHAMMAD ARIF NADEEM

Keywords:

Interferon, retinopathy and chronic hepatitis C

Abstract

Objectives: Hepatitis C virus (HCV) is a single-strand, positive sense ribonucleic acid (RNA) virus belonging to the flaviviridae family. Treatment of hepatitis C with interferon- ribavirin combination therapy has proved to be effective in terms of biochemical and virological response. Retinopathy (Retinal changes) is a well-recognized side effect of interferon therapy. Cases have been reported where patient of chronic hepatitis C being treated with interferon suffered from blindness. The objective of the study is to determine the retinal changes in patients of chronic hepatitis C who are on conventional interferon alpha- ribavirin combination therapy. Design: Descriptive case series. Place and duration of study: The study was conducted in Hepatitis Clinic, Medical Unit III Services Hospital Lahore. The study was carried out over a period of six months, from 25th August 2010 to 25th Feb. 2011. Method: One hundred and fifty were included in the study. Interferon and ribavirin combination therapy was then started in the dose of 3 million units subcutaneously thrice a week and 400mg orally thrice a day respectively. Fundoscopy was done by a single ophthalmologist in every patient after the week 6 and 12 of the start of therapy. The presence or absence of retinopathy with the detail of retinal changes was documented. Results: One hundred and fifty patients were enrolled in the study. Eighty eight patients (58.7%) were male and 62 (41.3%) female. One hundred and sixteen patients (77.3%) did not develop any retinal changes but remaining 34 patients (22.7%) suffered from retinopathy. Out of the total 34 patients who developed retinopathy, 13 patients (38.2%) had it in the form of retinal haemorrhages and 21 patients (61.8%) developed cotton wool spots. No patient suffered from macular oedema. Conclusion: It is concluded that every patient on interferon therapy should have regular eye examination for surveillance of retinopathy to prevent blindness, a dreadful consequence

Downloads

Published

2018-07-15

How to Cite

1.
MUHAMMAD ARIF NADEEM SJ. Retinal Changes: In Patients of Chronic Hepatitis C Treated with Interferon Alpha- Ribavirin Combination Therapy. J Fatima Jinnah Med Univ [Internet]. 2018 Jul. 15 [cited 2024 May 3];7(1). Available from: https://jfjmu.com/index.php/ojs/article/view/361

Issue

Vol. 7 No. 1 (2013): Journal of Fatima Jinnah Medical College

Section

Articles

License

The Journal of Fatima Jinnah Medical University follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC By-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of JFJMU strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.